LU90388B1 - Sel de paroxetine nouveau procede pour sa preparation et compositions pharmaceutiques le contenant - Google Patents

Sel de paroxetine nouveau procede pour sa preparation et compositions pharmaceutiques le contenant

Info

Publication number: LU90388B1
Authority: LU; Luxembourg
Prior art keywords: paroxetine methanesulfonate; neuroses; anxiety; depression; useful
Prior art date: 1998-07-02

Application number

LU90388A

Other languages

English (en)

Inventor

Simon Craig Dr Andrew

David Jones Dr Alan

O'keeffe Dr Deirde

Neal Ward Mr

Original Assignee

Smithkline Beecham Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-07-02

Filing date

1999-04-23

Publication date

2001-01-29

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27269380&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LU90388(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1998-07-02 Priority claimed from GBGB9814316.7A external-priority patent/GB9814316D0/en

1998-10-06 Priority claimed from GBGB9821732.6A external-priority patent/GB9821732D0/en

1999-02-10 Priority claimed from GBGB9902935.7A external-priority patent/GB9902935D0/en

1999-04-23 Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc

2001-01-29 Application granted granted Critical

2001-01-29 Publication of LU90388B1 publication Critical patent/LU90388B1/fr

Links

SHIJTGJXUHTGGZ-RVXRQPKJSA-N (3s,4r)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidin-1-ium;methanesulfonate Chemical compound CS(O)(=O)=O.C1=CC(F)=CC=C1[C@H]1[C@H](COC=2C=C3OCOC3=CC=2)CNCC1 SHIJTGJXUHTGGZ-RVXRQPKJSA-N 0.000 title abstract 4
208000019901 Anxiety disease Diseases 0.000 title 1
208000020401 Depressive disease Diseases 0.000 title 1
230000036506 anxiety Effects 0.000 title 1
238000002441 X-ray diffraction Methods 0.000 abstract 2
239000003814 drug Substances 0.000 abstract 1
239000012458 free base Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Inorganic Chemistry (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Psychology (AREA)
Rheumatology (AREA)
Diabetes (AREA)
Hematology (AREA)
Addiction (AREA)
Child & Adolescent Psychology (AREA)
Obesity (AREA)
Plural Heterocyclic Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Hydrogenated Pyridines (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

LU90388A 1998-07-02 1999-04-23 Sel de paroxetine nouveau procede pour sa preparation et compositions pharmaceutiques le contenant LU90388B1 (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GBGB9814316.7A GB9814316D0 (en)	1998-07-02	1998-07-02	Novel compounds
GBGB9821732.6A GB9821732D0 (en)	1998-10-06	1998-10-06	Novel compound
GBGB9902935.7A GB9902935D0 (en)	1999-02-10	1999-02-10	Novel compound

Publications (1)

Publication Number	Publication Date
LU90388B1 true LU90388B1 (fr)	2001-01-29

Family

ID=27269380

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
LU90388A LU90388B1 (fr)	1998-07-02	1999-04-23	Sel de paroxetine nouveau procede pour sa preparation et compositions pharmaceutiques le contenant

Country Status (34)

Country	Link
US (4)	US6063927A (fr)
EP (5)	EP1020463A1 (fr)
JP (1)	JP2002519422A (fr)
KR (1)	KR20010053336A (fr)
CN (1)	CN1127502C (fr)
AR (2)	AR011759A1 (fr)
AT (4)	AT3185U3 (fr)
AU (4)	AU732211C (fr)
BE (3)	BE1012403A5 (fr)
BR (1)	BR9911682A (fr)
CA (1)	CA2269999A1 (fr)
CH (1)	CH689805A8 (fr)
DE (5)	DE19918588A1 (fr)
DK (7)	DK1089996T3 (fr)
ES (4)	ES2209428T3 (fr)
FI (2)	FI112077B (fr)
FR (2)	FR2780728B1 (fr)
GB (5)	GB2339428A (fr)
GR (3)	GR990100140A (fr)
HU (1)	HUP0102334A3 (fr)
IE (5)	IES20000893A2 (fr)
IL (1)	IL140628A (fr)
IT (1)	IT1312540B1 (fr)
LU (1)	LU90388B1 (fr)
NL (4)	NL1011874C1 (fr)
NO (1)	NO319030B1 (fr)
NZ (1)	NZ509180A (fr)
PL (1)	PL345214A1 (fr)
PT (4)	PT102291B (fr)
SE (1)	SE9901462A0 (fr)
SI (3)	SI1020464T1 (fr)
SK (1)	SK20262000A3 (fr)
TR (1)	TR200100054T2 (fr)
WO (1)	WO2000001694A1 (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5998401A (en) *	1995-02-28	1999-12-07	Eli Lilly And Company	Naphthyl compounds, intermediates, compositions, and methods
ID24610A (id) *	1997-02-27	2000-07-27	Ajinomoto Kk	Radas serta metode untuk mengkristalisasian
AU3108097A (en) *	1997-06-10	1998-12-30	Synthon B.V.	4-phenylpiperidine compounds
CH689805A8 (fr) *	1998-07-02	2000-02-29	Smithkline Beecham Plc	Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
US20040028582A1 (en) *	1999-03-10	2004-02-12	Smithkline Beecham Corporation	Crystallization process for producing fine crystal products
USPP12225P2 (en)	1999-06-01	2001-11-27	Florfis Ag	Geranium plant named ‘Fislamda’
AU5078700A (en) *	1999-06-22	2001-01-09	Smithkline Beecham Plc	Novel composition
ES2159260B1 (es) *	1999-06-22	2002-05-01	Smithkline Beechan Plc	Nueva composicion de metanosulfonato de paroxetina
GB0003232D0 (en) *	2000-02-11	2000-04-05	Smithkline Beecham Plc	Novel composition
US6306435B1 (en)	2000-06-26	2001-10-23	Yung Shin Pharmaceutical Industrial Co. Ltd.	Oral pharmaceutical preparation embedded in an oily matrix and methods of making the same
GB0015981D0 (en) *	2000-06-29	2000-08-23	Glaxo Group Ltd	Novel process for preparing crystalline particles
CA2418038A1 (fr) *	2000-08-28	2002-03-07	Synthon B.V.	Compositions a base de paroxetine et leurs procedes de fabrication
DE20100529U1 (de) *	2001-01-11	2001-05-10	Synthon Bv	Pharmazeutische Tablette umfassend Paroxetinmesylat
NL1017421C2 (nl) *	2001-02-21	2002-01-15	Synthon Bv	Werkwijze voor het vervaardigen van paroxetine.
EP1412350A1 (fr) *	2001-08-02	2004-04-28	Spurcourt Limited	Sel d'isethionate de paroxetine, procede de preparation et utilisation dans le traitement de la depression
EP2316468A1 (fr)	2002-02-22	2011-05-04	Shire LLC	Système de distribution et méthodes de protection et d'administration de dextroamphetamine
US20050266082A1 (en) *	2004-05-26	2005-12-01	Patel Satishkumar A	Preparation of stable paroxetine HC1 ER tablets using a melt granulation process
WO2006018318A1 (fr) *	2004-08-18	2006-02-23	Synthon B.V.	Compositions liquides de paroxetine
US20060039975A1 (en) *	2004-08-20	2006-02-23	Zalman Vilkov	Paroxetine formulations
KR100672184B1 (ko)	2004-09-21	2007-01-19	주식회사종근당	파록세틴의 콜린산 또는 콜린산 유도체 염
WO2006110553A2 (fr) *	2005-04-07	2006-10-19	Xy, Inc.	Systeme conditionneur d'une voie d'ecoulement
CA2629514A1 (fr) *	2005-11-14	2007-05-24	Auspex Pharmaceuticals, Inc.	Phenylpiperidines substituees a activite serotoninergique et proprietes therapeutiques ameliorees
WO2007063384A2 (fr) *	2005-12-01	2007-06-07	Pfizer Products Inc.	Dérivés de pyrimidine pour le traitement de la croissance cellulaire anormale
US20080033050A1 (en)	2006-08-04	2008-02-07	Richards Patricia Allison Tewe	Method of treating thermoregulatory disfunction with paroxetine
EP2167493A1 (fr) *	2007-03-09	2010-03-31	Novartis AG	Sels de 3-(1h-indol-3-yl)-4-[2-(4-methyl-pipérazin-1-yl)-quinazolin-4-yl]-pyrrole-2,5-dione
US8119688B2 (en) *	2007-09-19	2012-02-21	Xy, Llc	Differential evaporation potentiated disinfectant system
US20100249166A1 (en) *	2007-09-19	2010-09-30	Xy, Inc.	Differential evaporation potentiated disinfectant system
FR2926552B1 (fr) *	2008-01-23	2010-03-26	Biocodex	Procede de preparation de particules de stiripentol ayant une granulometrie definie
CN103961333B (zh) *	2014-05-07	2020-02-21	浙江华海药业股份有限公司	甲磺酸帕罗西汀胶囊及其制备方法
CN104523645A (zh) *	2014-11-20	2015-04-22	美吉斯制药（厦门）有限公司	甲磺酸帕罗西汀片芯及其包衣片的制备方法
US11111373B2 (en)	2018-12-05	2021-09-07	Chi Mei Corporation	Polymethacrylate composition and optical device made therefrom, and display apparatus

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE99678C (fr) *
GB1422263A (en) *	1973-01-30	1976-01-21	Ferrosan As	4-phenyl-piperidine compounds
US4585777A (en) *	1984-02-07	1986-04-29	A/S Ferrosan	(-)-Trans-4-(4-fluorophenyl)-3-(4-methoxyphenoxy)methylpiperidine for potentiating 5-HT
GB8430581D0 (en) *	1984-12-04	1985-01-09	Ferrosan As	Treatment
GB8431478D0 (en) *	1984-12-13	1985-01-23	Beecham Group Plc	Compounds
EP0190496A3 (fr) *	1984-12-13	1987-05-27	Beecham Group Plc	Dérivés de la pipéridine à activité gastro-intestinale
GB8520154D0 (en) *	1985-08-10	1985-09-18	Beecham Group Plc	Chemical process
EP0223334B1 (fr) *	1985-08-10	1991-07-10	Beecham Group Plc	Procédé de préparation d'aryl-pipéridine-carbinols
EP0223430B1 (fr) *	1985-10-21	1991-02-27	Honda Giken Kogyo Kabushiki Kaisha	Méthode pour commander l'alimentation en courant du solénoide de la soupape électromagnétique qui commande l'alimentation en air d'un moteur à combustion interne
EP0223403B1 (fr) *	1985-10-25	1993-08-04	Beecham Group Plc	Dérivé de pipéridine, sa préparation et son utilisation comme médicament
IE66332B1 (en) *	1986-11-03	1995-12-27	Novo Nordisk As	Piperidine compounds and their preparation and use
GB8626936D0 (en) *	1986-11-11	1986-12-10	Ferrosan As	Treatment
EP0269383A3 (fr) *	1986-11-21	1990-05-02	A.H. Robins Company, Incorporated	1-Aryloxy-4-[(4-aryl)-1-pipérazinyl]-2-butanols utiles pour traiter des manifestations allergiques
GB8714707D0 (en) *	1987-06-23	1987-07-29	Beecham Group Plc	Chemical process
DK715988D0 (da) *	1988-12-22	1988-12-22	Ferrosan As	Etherifikation og dealkylering af piperidin-derivater samt intermediater
DK716088D0 (da) *	1988-12-22	1988-12-22	Ferrosan As	Reduktion af piperidin-dion-derivater samt intermediat
KR930702000A (ko) *	1990-11-24	1993-09-08	데이빗 로버츠	노년기 치매, 식용항진, 편두통, 또는 식용불량의 치료를 위한 파로세틴의 사용
GB9209687D0 (en) *	1992-05-06	1992-06-17	Smithkline Beecham Plc	Novel process
US5258517A (en) *	1992-08-06	1993-11-02	Sepracor, Inc.	Method of preparing optically pure precursors of paroxetine
JP2773587B2 (ja) *	1992-11-30	1998-07-09	東レ株式会社	Ｏ，ｏ´−ジアシル酒石酸無水物の製造法
US5276042A (en) *	1993-04-16	1994-01-04	Crenshaw Roger T	Treatment of premature ejaculation
US5546683A (en) *	1993-09-29	1996-08-20	Clark; George J.	Bucket attachment device with remote controlled retractable pins
IT1274241B (it) *	1993-12-03	1997-07-15	Smithkline Beecham Farma	Complessi agente terapeutico/matrice polimerica dotati di migliorate caratteristiche di sapore e composizioni farmaceutiche che li contengono
GB9325644D0 (en) *	1993-12-15	1994-02-16	Smithkline Beecham Plc	Novel formulation
US5668134A (en) *	1994-01-28	1997-09-16	G. D. Searle & Co.	Method for preventing or reducing photosensitivity and/or phototoxicity reactions to medications
GB9402029D0 (en) *	1994-02-03	1994-03-30	Smithkline Beecham Plc	Novel formulation
CA2143070C (fr) *	1994-02-22	2001-12-18	Pankaj Modi	Formulation pharmaceutique sous forme de suspension liquide administree par voie orale, pour degagement prolonge
EP0714663A3 (fr) *	1994-11-28	1997-01-15	Lilly Co Eli	Potentialisation d'un médicament par un antagoniste du récepteur sérotonine 1A
GB2297550C2 (en) *	1995-02-06	1997-04-09	Smithkline Beecham Plc	Paroxetine hydrochloride anhydrate substantially free of bound organic solvent
SK283608B6 (sk) *	1995-02-06	2003-10-07	Smithkline Beecham Plc	Bezvodý hydrochlorid paroxetínu, spôsob jeho výroby a použitie
MX9707585A (es) *	1995-04-03	1997-12-31	Abbott Lab	Mezclas homogeneas de farmacos y aditivos de fusion a baja temperatura para liberacion controlada.
HUP9900318A3 (en) *	1995-05-17	2001-09-28	Novo Nordisk As	Process for preparing 4-aryl-piperidine derivatives
JP2813768B2 (ja) *	1995-05-24	1998-10-22	農林水産省家畜衛生試験場長	口蹄疫診断用ペプチドおよび当該ペプチドを含有する口蹄疫診断用抗原
GB9514842D0 (en) *	1995-07-20	1995-09-20	Smithkline Beecham Plc	Novel formulation
AU701386B2 (en) *	1995-10-31	1999-01-28	Merck & Co., Inc.	Process for preparing substituted azetidinones
IT1276160B1 (it) *	1995-11-22	1997-10-27	Recordati Chem Pharm	Composizioni farmaceutiche orali a pronto rilascio per sospensioni estemporanee
GB9526645D0 (en) *	1995-12-28	1996-02-28	Chiroscience Ltd	Stereoselective synthesis
ES2117557B1 (es) *	1996-02-29	1999-07-01	Ferrer Int	Nuevo procedimiento de obtencion de (-)-trans -n-p-fluorobenzoilmetil-4-(p-fluorofenil)-3- ((3,4-(metilendioxi)fenoxi ) metil)-piperidina.
JP3446468B2 (ja) *	1996-04-15	2003-09-16	旭硝子株式会社	ピペリジンカルビノール類の製造方法
CA2206592A1 (fr) *	1996-05-30	1997-11-30	Shu-Zhong Wang	Methode de preparation de chlorhydrate de paroxetine amorphe
JP3882224B2 (ja) *	1996-05-31	2007-02-14	旭硝子株式会社	パロキセチンの製造方法
EP0812827B1 (fr) *	1996-06-13	2009-09-02	Sumitomo Chemical Company, Limited	Dérivés de pipéridine comme intermédiaire pour la production de paroxétine et procédé pour leur préparation
HU221921B1 (hu) *	1996-07-08	2003-02-28	Richter Gedeon Vegyészeti Gyár Rt.	N-benzil-piperidin- és tetrahidropiridinszármazékok és eljárás azok előállítására
US5672609A (en) *	1996-07-18	1997-09-30	Eli Lilly And Company	Pyridine compounds, intermediates compositions and methods of use
CA2187128A1 (fr) *	1996-10-04	1997-06-26	K. S. Keshava Murthy	Polymorphe nouveau et efficace, a base de chlorhydrate de paroxetine anhydre
AU3108097A (en) *	1997-06-10	1998-12-30	Synthon B.V.	4-phenylpiperidine compounds
CA2319652A1 (fr) *	1998-02-06	1999-08-12	Michael Urquhart	Sels de paroxetine
PL342931A1 (en) *	1998-03-16	2001-07-16	Smithkline Beecham Plc	Crystalline form of paroxetine
EA200001050A1 (ru) *	1998-04-09	2001-04-23	Смитклайн Бичам Плс	Малеат пароксетина
CH689805A8 (fr) *	1998-07-02	2000-02-29	Smithkline Beecham Plc	Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
ES2159260B1 (es) *	1999-06-22	2002-05-01	Smithkline Beechan Plc	Nueva composicion de metanosulfonato de paroxetina
DE20100529U1 (de) *	2001-01-11	2001-05-10	Synthon Bv	Pharmazeutische Tablette umfassend Paroxetinmesylat

1999
- 1999-04-20 CH CH00723/99A patent/CH689805A8/fr not_active IP Right Cessation
- 1999-04-23 ES ES99918159T patent/ES2209428T3/es not_active Expired - Lifetime
- 1999-04-23 DK DK99918159T patent/DK1089996T3/da active
- 1999-04-23 IE IE20000893A patent/IES20000893A2/en not_active IP Right Cessation
- 1999-04-23 FR FR9905185A patent/FR2780728B1/fr not_active Expired - Fee Related
- 1999-04-23 NZ NZ509180A patent/NZ509180A/en unknown
- 1999-04-23 PL PL99345214A patent/PL345214A1/xx not_active Application Discontinuation
- 1999-04-23 EP EP00201289A patent/EP1020463A1/fr not_active Withdrawn
- 1999-04-23 IL IL14062899A patent/IL140628A/en not_active IP Right Cessation
- 1999-04-23 IE IE19990344A patent/IE990344A1/en not_active IP Right Cessation
- 1999-04-23 EP EP02078483A patent/EP1288214A1/fr not_active Withdrawn
- 1999-04-23 WO PCT/GB1999/001253 patent/WO2000001694A1/fr not_active Ceased
- 1999-04-23 GB GB9920332A patent/GB2339428A/en not_active Withdrawn
- 1999-04-23 BR BR9911682-0A patent/BR9911682A/pt not_active Application Discontinuation
- 1999-04-23 DK DK199900176U patent/DK199900176U3/da not_active IP Right Cessation
- 1999-04-23 CN CN99810281A patent/CN1127502C/zh not_active Expired - Fee Related
- 1999-04-23 GB GB9909505A patent/GB2336364B/en not_active Revoked
- 1999-04-23 AU AU23928/99A patent/AU732211C/en not_active Ceased
- 1999-04-23 PT PT102291A patent/PT102291B/pt not_active IP Right Cessation
- 1999-04-23 BE BE9900293A patent/BE1012403A5/fr not_active IP Right Cessation
- 1999-04-23 DE DE19918588A patent/DE19918588A1/de not_active Ceased
- 1999-04-23 GB GB0026487A patent/GB2352395B/en not_active Expired - Fee Related
- 1999-04-23 IT IT1999MI000866A patent/IT1312540B1/it active
- 1999-04-23 DE DE69911774T patent/DE69911774T2/de not_active Expired - Fee Related
- 1999-04-23 AU AU23937/99A patent/AU713131B3/en not_active Ceased
- 1999-04-23 AR ARP990101885A patent/AR011759A1/es not_active Application Discontinuation
- 1999-04-23 AU AU36191/99A patent/AU3619199A/en not_active Abandoned
- 1999-04-23 PT PT79901275T patent/PT1020464E/pt unknown
- 1999-04-23 TR TR2001/00054T patent/TR200100054T2/xx unknown
- 1999-04-23 PT PT99918159T patent/PT1089996E/pt unknown
- 1999-04-23 KR KR1020007015099A patent/KR20010053336A/ko not_active Withdrawn
- 1999-04-23 FI FI990922A patent/FI112077B/fi active
- 1999-04-23 GR GR990100140A patent/GR990100140A/el not_active IP Right Cessation
- 1999-04-23 SI SI9930009T patent/SI1020464T1/xx unknown
- 1999-04-23 IE IE20000894A patent/IES20000894A2/en not_active Application Discontinuation
- 1999-04-23 SI SI9930002T patent/SI0970955T1/xx unknown
- 1999-04-23 PT PT99303151T patent/PT970955E/pt unknown
- 1999-04-23 DE DE29907248U patent/DE29907248U1/de not_active Expired - Lifetime
- 1999-04-23 DK DK199900554A patent/DK199900554A/da not_active Application Discontinuation
- 1999-04-23 FI FI990190U patent/FI4209U1/fi not_active IP Right Cessation
- 1999-04-23 EP EP99918159A patent/EP1089996B1/fr not_active Expired - Lifetime
- 1999-04-23 NL NL1011874A patent/NL1011874C1/nl not_active IP Right Cessation
- 1999-04-23 NO NO19991944A patent/NO319030B1/no unknown
- 1999-04-23 JP JP2000558097A patent/JP2002519422A/ja active Pending
- 1999-04-23 CA CA002269999A patent/CA2269999A1/fr not_active Abandoned
- 1999-04-23 SE SE9901462A patent/SE9901462A0/sv not_active Application Discontinuation
- 1999-04-23 AT AT0027999U patent/AT3185U3/de not_active IP Right Cessation
- 1999-04-23 AT AT99918159T patent/ATE251155T1/de not_active IP Right Cessation
- 1999-04-23 GB GB0216752A patent/GB2377637A/en not_active Withdrawn
- 1999-04-23 NL NL1011875A patent/NL1011875C2/nl not_active IP Right Cessation
- 1999-04-23 ES ES99303151T patent/ES2149044T3/es not_active Expired - Lifetime
- 1999-04-23 DE DE69900007T patent/DE69900007T2/de not_active Revoked
- 1999-04-23 EP EP99303151A patent/EP0970955B1/fr not_active Revoked
- 1999-04-23 US US09/299,060 patent/US6063927A/en not_active Expired - Fee Related
- 1999-04-23 AU AU23938/99A patent/AU713877B3/en not_active Ceased
- 1999-04-23 GB GB0119695A patent/GB2367003A/en not_active Withdrawn
- 1999-04-23 LU LU90388A patent/LU90388B1/fr active
- 1999-04-23 DK DK99303151T patent/DK0970955T3/da active
- 1999-04-23 IE IE19990343 patent/IES81166B2/en not_active IP Right Cessation
- 1999-04-23 ES ES009900849A patent/ES2158778B1/es not_active Expired - Fee Related
- 1999-04-23 IE IE20000633A patent/IE20000633A1/en not_active IP Right Cessation
- 1999-04-23 AT AT99303151T patent/ATE195121T1/de not_active IP Right Cessation
- 1999-04-23 SK SK2026-2000A patent/SK20262000A3/sk unknown
- 1999-04-23 SI SI9930482T patent/SI1089996T1/xx unknown
- 1999-04-23 HU HU0102334A patent/HUP0102334A3/hu unknown
- 1999-04-23 BE BE9900294A patent/BE1011664A6/fr not_active IP Right Cessation
- 1999-04-23 EP EP00201290A patent/EP1020464B1/fr not_active Revoked
- 1999-04-26 AR ARP990101908A patent/AR018197A1/es unknown
- 1999-06-08 NL NL1012271A patent/NL1012271C2/nl not_active IP Right Cessation
- 1999-06-08 NL NL1012272A patent/NL1012272C1/nl not_active IP Right Cessation
- 1999-06-15 DK DK199900234U patent/DK199900234U4/da not_active IP Right Cessation
- 1999-12-23 BE BE9900832A patent/BE1012420A6/fr not_active IP Right Cessation
2000
- 2000-04-10 ES ES00201290T patent/ES2157881T3/es not_active Expired - Lifetime
- 2000-04-10 DK DK00201290T patent/DK1020464T3/da active
- 2000-04-10 AT AT00201290T patent/ATE202777T1/de not_active IP Right Cessation
- 2000-04-10 DE DE60000003T patent/DE60000003T2/de not_active Revoked
- 2000-09-05 GR GR20000402015T patent/GR3034328T3/el not_active IP Right Cessation
- 2000-11-08 FR FR0014325A patent/FR2802098A1/fr active Pending
- 2000-12-27 DK DK200000390U patent/DK200000390U1/da not_active IP Right Cessation
2001
- 2001-03-14 US US09/805,812 patent/US20010023253A1/en not_active Abandoned
- 2001-07-11 GR GR20010401061T patent/GR3036208T3/el not_active IP Right Cessation
- 2001-09-21 US US09/960,033 patent/US20020035130A1/en not_active Abandoned
2002
- 2002-06-18 US US10/174,380 patent/US20020193406A1/en not_active Abandoned

Also Published As

Publication number	Publication date
BE1011664A6 (fr)	1999-11-09
GB2336364A (en)	1999-10-20
DK200000390U1 (da)	2000-12-27
AR018197A1 (es)	2001-10-31
HUP0102334A3 (en)	2003-12-29
NL1012272C1 (nl)	1999-07-12
DK0970955T3 (da)	2000-10-09
AU713131B3 (en)	1999-11-25
BE1012420A6 (fr)	2000-10-03
DK199900234U4 (da)	2000-12-22
NL1011875C2 (nl)	2000-03-24
ES2157881T3 (es)	2001-09-01
GB0119695D0 (en)	2001-10-03
GB0216752D0 (en)	2002-08-28
ATE195121T1 (de)	2000-08-15
DE69900007T2 (de)	2001-06-07
IL140628A0 (en)	2002-02-10
HK1037877A1 (en)	2002-02-22
CH689805A5 (fr)	1999-11-30
GB2367003A (en)	2002-03-27
FIU990190U0 (fi)	1999-04-23
FR2780728B1 (fr)	2001-02-16
AU3619199A (en)	2000-01-24
NL1012271A1 (nl)	1999-07-12
PT1089996E (pt)	2004-02-27
EP1020463A1 (fr)	2000-07-19
EP0970955B1 (fr)	2000-08-02
TR200100054T2 (tr)	2001-06-21
NL1011874C1 (nl)	1999-07-12
CH689805A8 (fr)	2000-02-29
AR011759A1 (es)	2000-09-13
GB9909505D0 (en)	1999-06-23
FI990922L (fi)	2000-01-03
ATE251155T1 (de)	2003-10-15
EP1089996A1 (fr)	2001-04-11
DK199900234U1 (da)	2000-12-22
DE69900007D1 (de)	2000-09-07
IL140628A (en)	2004-06-20
DE60000003D1 (de)	2001-08-09
BE1012403A5 (fr)	2000-10-03
GB2336364B (en)	2000-05-10
PT102291A (pt)	2000-05-31
DK1089996T3 (da)	2004-02-09
HUP0102334A2 (hu)	2002-05-29
IES20000893A2 (en)	2001-05-30
US20020035130A1 (en)	2002-03-21
CN1315949A (zh)	2001-10-03
NO319030B1 (no)	2005-06-06
GB2352395A (en)	2001-01-31
GR990100140A (el)	2000-03-31
US20020193406A1 (en)	2002-12-19
GB2377637A (en)	2003-01-22
PT970955E (pt)	2000-11-30
GR1003350B (el)	2000-03-29
IES81166B2 (en)	2000-05-31
GB9920332D0 (en)	1999-11-03
PT102291B (pt)	2002-07-31
GR3036208T3 (en)	2001-10-31
EP0970955A1 (fr)	2000-01-12
IE990344A1 (en)	2000-05-03
SK20262000A3 (sk)	2001-07-10
EP1020464B1 (fr)	2001-07-04
DE60000003T2 (de)	2002-03-21
CA2269999A1 (fr)	2000-01-02
ES2158778B1 (es)	2002-03-16
SI1020464T1 (en)	2001-12-31
NO991944D0 (no)	1999-04-23
IES990343A2 (en)	2000-01-02
AU732211C (en)	2004-05-06
DK199900554A (da)	2000-01-03
EP1288214A1 (fr)	2003-03-05
US6063927A (en)	2000-05-16
GB2352395B (en)	2004-02-11
SI0970955T1 (en)	2001-02-28
BR9911682A (pt)	2001-12-26
FR2780728A1 (fr)	2000-01-07
AU732211B2 (en)	2001-04-12
FI112077B (fi)	2003-10-31
SI1089996T1 (en)	2004-04-30
IT1312540B1 (it)	2002-04-22
US20010023253A1 (en)	2001-09-20
FI4209U1 (fi)	1999-11-10
DE19918588A1 (de)	2000-01-27
NL1012271C2 (nl)	1999-09-23
NO991944L (no)	2000-01-03
DK199900176U3 (da)	1999-08-13
GB2339428A (en)	2000-01-26
AT3185U2 (de)	1999-11-25
DE69911774D1 (de)	2003-11-06
SE9901462D0 (sv)	1999-04-23
GB0026487D0 (en)	2000-12-13
EP1089996B1 (fr)	2003-10-01
PL345214A1 (en)	2001-12-03
IE20000633A1 (en)	2001-10-17
SE9901462L (fr)
ES2149044T3 (es)	2000-10-16
ATE202777T1 (de)	2001-07-15
ES2158778A1 (es)	2001-09-01
ES2209428T3 (es)	2004-06-16
GR3034328T3 (en)	2000-12-29
ITMI990866A1 (it)	2000-10-23
PT1020464E (pt)	2001-10-30
IES20000894A2 (en)	2001-05-30
AU713877B3 (en)	1999-12-09
DK1020464T3 (da)	2001-09-24
DE29907248U1 (de)	1999-09-09
NL1011875A1 (nl)	2000-01-07
AT3185U3 (de)	2000-01-25
NZ509180A (en)	2001-06-29
KR20010053336A (ko)	2001-06-25
FI990922A0 (fi)	1999-04-23
JP2002519422A (ja)	2002-07-02
WO2000001694A1 (fr)	2000-01-13
EP1020464A1 (fr)	2000-07-19
SE9901462A0 (sv)	2000-01-03
DE69911774T2 (de)	2004-08-05
CN1127502C (zh)	2003-11-12
FR2802098A1 (fr)	2001-06-15
AU2392899A (en)	2000-01-20

Publication	Publication Date	Title
LU90388B1 (fr)	2001-01-29	Sel de paroxetine nouveau procede pour sa preparation et compositions pharmaceutiques le contenant
SI1304327T1 (fr)	2005-08-31
ZA981953B (en)	1999-09-09	Device for controlled anaesthesia, analgesia and/or sedation.
MXPA02011427A (es)	2004-09-10	Procedimiento para revestir dispositivos medicos utilizando dioxido de carbono supercritico.
PL331091A1 (en)	1999-06-21	Therapeutic multispecific compounds encompassing antibodies against the fcalpha receptor
GB2352544B (en)	2004-04-21	Method and system for delivering integrated user assistance information and traditional help from the same source
GB9514473D0 (en)	1995-09-13	Chemical compounds
ZA971397B (en)	1997-08-22	Undercutting surgical instrument.
IT1307047B1 (it)	2001-10-23	Apparecchiatura per il trattamento umidificato dell'apnea da sonno.
CY1108348T1 (el)	2014-02-12	Υποκατεστημενα 2-(2,6-διοξοπιπεριδιν-3-υλ)-φθαλιμιδια και μεθοδος μειωσης των tnf αλφα επιπεδων
TR199700049A2 (tr)	1997-08-21	Düsük CO'lu sigara.
GB2326321B (en)	1999-08-11	Method device, and article of manufacture for neural - network based generation of postlexical pronunciations from lexical pronunciations
IL131086A0 (en)	2001-01-28	The use of levobupivacaine in paediatric surgery
AU3745795A (en)	1996-05-06	Use of CCK-B receptor antagonists for the treatment of sleepdisorders
ZA981779B (en)	1999-03-03	The use of levobupivacaine in facial surgery
GB9824437D0 (en)	1999-01-06	Gene therapy
GB9804886D0 (en)	1998-04-29	Therapeutic combination
MXPA03011306A (es)	2004-03-19	Metodos para la preparacion y uso de 1a,24 (s) - hidroxivitamina d2.
EP0440174A3 (en)	1992-03-18	Method of controlling sound source for electronic musical instrument, and electronic musical instrument adopting the method
BG104038A (en)	2001-04-30	Use of specific antagonist of 5ht2 receptors for preparing medicines useful for treating sleep-disordered breathing
IT1297715B1 (it)	1999-12-20	Procedimento e dispositivo per l'agugliatura di un nastro di ovatta.
ZA977754B (en)	1998-02-23	Method and device for generating hydrogen and oxygen.
AU1463088A (en)	1988-10-20	Receptor of the small rhinovirus receptor group
GB9916729D0 (en)	1999-09-15	Fuller for the treatment of leather,pelts and the like
FR2742995B1 (fr)	1998-03-06	Sonde pour dispositif medical implante, notamment pour stimulateur cardiaque